WELCOME TO
A fresh approach to Life Science PR & Marketing
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.
Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:
The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
.@CN_Bio today announced that the @US_FDA has extended their #research collaboration to investigate the Company's lung-on-a-chip model for inhaled #drug evaluation applications.
Read more: https://t.co/sqiOnj7S1w
#biotechnology #drugdevelopment
.@hel_group today announced the appointment of its Asia-Pacific Sales Director, Brice Oh. Brice will oversee the expansion of the Company’s commercial presence, focusing on building a network of dealers and agents across the Asia-Pacific region.
Read: https://t.co/zJF46kd3le
As part of #teamtuesday we want to share what it's like to work with an award winning #lifescience #PR team. If you're interested in applying for a role, visit our website for more details: https://t.co/BgpqlLzzpA #hiring
.@Mogrify_UK announced the second close of its Series A financing, bringing the total raised to $33MUSD. The #funding will support #immuno-oncology & #ophthalmology programs, and the exploration of #cellreprogramming for novel therapeutic application. Read https://t.co/RngGTPqbN5
We are looking forward to #BioIntegrates taking place virtually on 20 May where the focus will be on the major challenges impacting the #biotechnology sector.
To register: https://t.co/epHewPxbh7
Turbine today announced its Chairman, Dr. Mark Velleca, as well as the expansion of its Scientific Advisory Board, with the addition of Prof. Gordon Mills and Dr. Klaus Hoeflich.
Read: https://t.co/PPe0OEjiMA
#drugdiscovery #ai
